LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NYSE:LRN), LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the […]

LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LRN Investors Have Opportunity to Lead Stride, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 22, 2025 LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) for

Click’s Journey AI Announces Integration Partnership with 8amMyCase to Streamline Law Firm Lead Intake & Client Follow Up

Santa Barbara, CA , Dec. 22, 2025 (GLOBE NEWSWIRE) — Click's Journey AI, a leading marketing automation and analytics platform for law firms, is thrilled to announce its official integration partnership with 8amMyCase, a premier legal practice management software. This strategic collaboration enhances the ability of law firms to streamline operations, improve client engagement, and

Click’s Journey AI Announces Integration Partnership with 8amMyCase to Streamline Law Firm Lead Intake & Client Follow Up

Click's Journey AI Announces Integration Partnership with 8amMyCase to Streamline Law Firm Lead Intake & Client Follow Up Click's Journey AI Announces Integration Partnership with 8amMyCase to Streamline Law Firm Automation GlobeNewswire December 22, 2025 Santa Barbara, CA , Dec. 22, 2025 (GLOBE NEWSWIRE) — Click's Journey AI, a leading marketing automation and analytics platform

Quantum eMotion Becomes Top Holding in Defiance Quantum ETF

Montreal, Quebec–(Newsfile Corp. – December 22, 2025) – Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (FSE: 34Q0), a Canadian leader in quantum-safe cybersecurity, today announced that it has become the largest single holding of the Defiance Quantum ETF, marking a major milestone in institutional adoption of quantum security technologies. Following the BlueStar Quantum Computing and

FFIV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that F5, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / December 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against F5, Inc. (NASDAQ:FFIV) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal

Washington Examiner Appoints Veteran Journalist Bob Cusack as Executive Editor

Washington, DC, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Washington Examiner today announced that Bob Cusack, longtime editor in chief of The Hill and one of Washington's most respected newsroom leaders, has joined the organization as executive editor, a newly created role reporting to editorial director Hugo Gurdon. Cusack's arrival reunites one of the capital's

Washington Examiner Appoints Veteran Journalist Bob Cusack as Executive Editor

Washington Examiner Appoints Veteran Journalist Bob Cusack as Executive Editor GlobeNewswire December 22, 2025 Washington, DC, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Washington Examiner today announced that Bob Cusack, longtime editor in chief of The Hill and one of Washington's most respected newsroom leaders, has joined the organization as executive editor, a newly created

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:TLX), LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ: TLX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 22, 2025 LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited (“Telix” or “the Company”) (NASDAQ:

Scroll to Top